Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer – OncLive
OncLive |
Grant Aims to Deliver First Stem–Cell Immunotherapy in Ovarian Cancer
OncLive The New York State Stem Cell Science Program (NYSTEM) recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute (RPCI) in Buffalo, New York, to fund research and development of a stem–cell based treatment for ovarian cancer. |
